The earnings call highlighted several positive developments, including strong cash flow, significant SG&A cost reductions, and growth in key business areas such as the care gap closure program and medical transportation. However, these were offset by a substantial decline in overall revenue and a negative EBITDA, mainly due to the wind down of migrant-related projects. The company is focusing on leveraging its strong balance sheet and operational efficiencies to drive future growth.

Company Guidance

During the DocGo Second Quarter Earnings Call, CEO Lee Bienstock highlighted several key metrics indicating strong performance and strategic advancements. The company reported a significant increase in cash flow from operations, totaling over $30 million, and a reduction in migrant-related accounts receivable from approximately $120 million to $54 million. Additionally, total cash, including restricted cash and investments, rose to $128.7 million, up by $25.6 million from the previous quarter. DocGo also achieved operational efficiency by reducing SG&A, resulting in an estimated $10 million in annualized savings. The company completed over 176,000 medical transports, 6,000 gap closure and transitional care management visits, and 28,000 mobile phlebotomy visits. They also expanded their care gap closure program, increasing patient engagement to 1.2 million lives from 900,000 in the previous quarter, with a 50% increase in patient conversions. The medical transportation segment saw 176,000 transports, partly driven by a new customer launch in New York. Despite a decline in total revenue to $80.4 million due to a wind-down in government verticals, the medical transportation services revenue increased slightly to $49.6 million. DocGo anticipates ending the year with more than 31,000 care gap visits and aims to increase this figure to over 54,000 by 2026.

Strong Cash Flow and Balance Sheet Improvement

The company reported over $30 million in cash flow from operations, reducing migrant-related accounts receivable from $120 million to $54 million. Total cash increased to $128.7 million, up $25.6 million from the previous quarter.

SG&A Cost Reductions

Substantial reduction in SG&A was achieved, resulting in an estimated $10 million annualized savings, with further plans to optimize business structure.

Growth in Care Gap Closure Program

The program expanded significantly, engaging with over 1.2 million assigned lives, up from 900,000, with a 50% increase in patient conversions in Q2.

Advancements in Medical Transportation

176,000 transports were completed, with integration and expansion in key markets, including a new launch in New York and a multiyear deal with the Albany Stratton VA Medical Center.

AI Integration in Operations

An AI agent was developed to automate appointment reminders, confirmations, and rescheduling, saving 10% of operators' time.

DocGo (DCGO) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

DCGO Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 10, 2025	2025 (Q3)	-0.13 / -	0.05	―	―	―
Aug 07, 2025	2025 (Q2)	-0.10 / -0.11	0.06	-283.33% (-0.17)	―
May 08, 2025	2025 (Q1)	-0.03 / -0.09	0.1	-190.00% (-0.19)	―
Feb 27, 2025	2024 (Q4)	0.04 / -0.03	0.075	-140.00% (-0.10)	―
Nov 07, 2024	2024 (Q3)	0.04 / 0.05	0.05	0.00% (0.00)	―
Aug 07, 2024	2024 (Q2)	0.06 / 0.06	-0.02	400.00% (+0.08)	―
May 08, 2024	2024 (Q1)	0.08 / 0.10	-0.03	433.33% (+0.13)	―
Feb 28, 2024	2023 (Q4)	0.10 / 0.07	0.11	-31.82% (-0.04)	―
Nov 06, 2023	2023 (Q3)	0.06 / 0.05	0.03	66.67% (+0.02)	―
Aug 07, 2023	2023 (Q2)	0.03 / -0.02	0.11	-118.18% (-0.13)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

DCGO Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 07, 2025	$1.39	$1.57	+12.95%
May 08, 2025	$2.33	$1.40	-39.91%
Feb 27, 2025	$3.92	$3.09	-21.17%
Nov 07, 2024	$3.61	$4.00	+10.80%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does DocGo (DCGO) report earnings?

DocGo (DCGO) is schdueled to report earning on Nov 10, 2025, After Close (Confirmed).

What is DocGo (DCGO) earnings time?

DocGo (DCGO) earnings time is at Nov 10, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is DCGO EPS forecast?

DCGO EPS forecast for the fiscal quarter 2025 (Q3) is -0.13.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing